Il 17 Receiptor A Antigen Binding Proteins

As on 04 September 2018

Patent Information

Application ID 2350/CHENP/2009
Applicants
Inventors
Invention Field Chemical
Date of Application 2009-04-28
Publication Number 29/2009
Publication Type INA
Ipc Classification C07K 16/28
International Application No PCT/US2007/021174
International Filing Date 2007-10-01
Priority Date
Examination Date 2010-07-21
Additional Email iprdel@lakshmisri.com
Updated Email null

Specification

Similar Patents

Il 18 Receptor Antigen Binding Proteins

Provided Herein Are Il 18 Receptor Antigen Binding Proteins And Polynucleotides Encoding The Same. Expression Vectors And Host Cells Comprising The Same For Production Of The Antigen Binding Proteins Are Also Provided. In Addition, Provided Are Co...

Truncated Il 17ra Soluble Receptor And Methods Of Using In Inflammation

The Present Invention Relates To Blocking, Inhibiting, Reduceing, Antagonizing Or Neutralizing The Activity Of Il 17a Alone, Or Both 1l 17a And Il 17f Polypeptide Molecules. 1l 17a And Il 17f Are Cytokines That Are Involved In Inflammatory Process...

Anti Kit Antibodies And Uses Thereof

Provided Herein In One Aspect Are Antibodies That Immunospecifically Bind To A Human Kit Antigen Comprising The Fourth And/Or Fifth Extracellular Ig Like Domains (That Is D4 And/Or D5 Domains) Polynucleotides Comprising Nucleotide Sequences Encodi...

Antibodies Directed To Her 3 And Uses Thereof

Abstract Antibodies Directed To Her 3 And Uses Thereof The Present Invention Relates To Binding Proteins That Bind To Her 3 And Polynucleotides Encoding The Same. Expression Vectors And Host Cells Comprising The Same For The Production Of The Bi...

Bcma Antigen Binding Proteins

The Present Invention Relates To Bcma (B Cell Maturation Antigen) Antigen Binding Proteins Such As Antibodies Polynucleotide Sequences Encoding Said Antigen Binding Proteins And Compositions And Methods For Diagnosing And Treating Diseases. The Pr...

Binding Molecules Specific For Her3 And Uses Thereof

The Present Invention Relates To Antibodies And Antigen Binding Fragments Thereof That Bind The Extracellular Domain Of The Her3 Receptor And Inhibit Various Her3 Receptor Related Functions Via Ligand Dependent And/Or Ligand Independent Mechanisms...

Interleukin 21 Receptor Binding Proteins

The Present Invention Provides Binding Proteins And Antigen Binding Fragments Thereof That Specifically Bind To The Human Interleukin 21 Receptor (Il 21r). The Binding Proteins Can Act As, E.G., Antagonists Of Il 21r Activity, Thereby Modulating I...

Methods Of Treatment Utilizing Binding Proteins Of The Interleukin 21 Receptor

The Present Invention Provides Binding Proteins And Antigen Binding Fragments Thereof, Including Human Antibodies, That Specifically Bind To The Human Interleukin 21 Receptor (Il 21r), And Methods Of Using Them. The Binding Proteins Can Act As, E....

Patent Registration

Rs 56,340/-
Patent Registration
Patent Documents
34
Documents Available